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Interactions between stromal organizer cells and hematopoietic lymphoid inducer cells initiate lymph-node
formation. In this issue of Immunity, Be´ne´zech et al. demonstrate that adipocyte precursors give rise to
lymph-node stromal organizer cells, illuminating an important step in lymphoid-tissue development.Lymph nodes (LNs) serve as meeting
points for antigen-presenting cells and
lymphocytes; they are strategically dis-
tributed in the entire body to facilitate
the initiation of immune responses and
to regulate immunological memory. Un-
like other lymphoid organs, such as
the thymus, LNs are not present in all
vertebrates; built into the evolutionarily
older lymphatic system, LNs are only
found in mammals, whereas reptiles
and birds possess primordial lymph-
node-like structures (Boehm et al.,
2012). LNs are commonly referred to
as secondary lymphoid organs for dis-
tinguishing them from primary lymphoid
tissue—in which lymphocyte develop-
ment takes place—and tertiary lym-
phoid tissue, which, although anatomi-
cally and functionally equivalent to
lymph nodes, develops as a conse-
quence of enduring inflammation. Hence,
there is significant interest in gaining
a better understanding of the cellular
and molecular sequence of lymphoid-
tissue formation (Koning and Mebius,
2012).The development of LNs during
embryogenesis and postnatal periods
has been investigated in great detail (Kon-
ing and Mebius, 2012). Put in simple
terms, it proceeds as follows: a special-
ized microenvironment consisting of so-
called lymphoid-tissue organizer (LTo)
cells attracts and interacts with a partic-
ular subset of innate lymphoid cells,
termed lymphoid-tissue inducer (LTi)
cells. Although much has been learned
about the nature and activity of LTi cells
(Cherrier and Eberl, 2012), little is known
about LTo cells. This enigmatic cell type
is the focus of the Be´ne´zech et al. (2012)
paper published in this issue of Immunity.
Be´ne´zech et al. have used a clever combi-
nation of detailed cellular phenotyping,
ingenious manipulation of genetically
modified embryonic tissue grafts, and
in vitro differentiation experiments to
identify the developmental progenitors of
LTo cells. Because LNs develop in close
association with fat deposits, the authors
hypothesized that adipocytes and
lymph-node stromal cells, both of mesen-
chymal origin, might be developmentallyrelated. In support of this notion, the
analysis of cell-surface-marker profiles
revealed strong similarities between pre-
sumptive preadipocytes isolated from fat
pads and stromal cell populations present
in inguinal lymph nodes. Intriguingly,
Be´ne´zech et al. found that shared cell-
surface receptors included the lympho-
toxin b receptor (LTbR). Knowing that
signaling through LTbR is crucial for
lymph-node formation (Ruddle and
Akirav, 2009), they examined the effect
of engaging this signaling pathway in pre-
adipocytes and found that LTbR signaling
activates the alternative NF-kB signaling
pathway and thus inhibits differentiation
to mature adipocytes. As a result, preadi-
pocytes begin to express a group of
genes characteristic of LN stromal cells,
namely those encoding chemokines,
such as Cxcl13, Ccl21, and Ccl19, and
cell-adhesion molecules, such as Icam1
and Vcam1. In short, LTbR signaling
diverts preadipocytes into a cell type
resembling LTo cells. In tissue-grafting
experiments, Be´ne´zech et al. then estab-
lished that embryonic preadipocytes
Figure 1. Early Steps of Lymph-Node Development
Mesenchymal progenitor cells give rise to preadipocytes that express LTbR. Most preadipocytes develop
along a default pathway into mature adipocytes constituting white fad pads. However, nerve cells situated
in close spatial proximity to some preadipocytes provide, in paracrine fashion, retinoic acid to induce the
expression of Cxcl13; this chemokine attracts LTi cells, which cluster together and, upon reciprocal
signaling through RANK-RANKL, upregulate the expression of LTa1b2, the ligand of LTbR, on their
surface. Engagement of LTbR by LTa1b2 blocks adipocyte differentiation and instead reprograms preadi-
pocytes to assume the phenotype of LTo cells. This differentiation initiates a feed-forward loop of LTo-LTi
interactions eventually leading to LN formation.
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Previewsmigrate into immature lymph-node
anlagen to become integrated into the
developing stromal network of the lymph
node, and they noted that this facility
is preserved in adult preadipocytes.
Crucially, migration of preadipocytes to
lymph nodes (and hence their possibility
of becoming integrated into the stromal
compartment) was shown to be depen-
dent on LTbR signaling. In conclusion,
the work of Be´ne´zech et al. identifies the
cellular origin of lymph-node stromal cells
as a subset of LTbR-expressing preadipo-
cytes and suggests a mechanism by
which these cells become integrated into
lymphoid tissue.
Despite their elegance and convincing
outcome, the results of Be´ne´zech et al.
do not provide an explanation for why
only a subset of preadipocytes becomes
reprogrammed to lymph-node stroma. In
other words, what could be the mecha-
nism ensuring that LTbR signaling
engages only part, but not all, of the pop-
ulation of preadipocytes in the fat pad? A
solution to this conundrum could be thespatially restricted provision of the LTbR
ligand, LTa1b2. But how is that achieved?
In earlier work (van de Pavert et al., 2009),
it was shown that retinoic acid induces the
expression of theCxcl13 chemokine gene
in prospective lymph-node organizer cells
and thus establishes a localized source of
attractant that leads to the clustering of
LTi cells (which happen to express the
Ccxl13 receptor, Cxcr5) in the vicinity of
LTo cells. The close proximity of LTi cells
in the resulting aggregates might allow for
reciprocal engagement of RANK receptor
and RANK ligand, which are both ex-
pressed on the surface of LTi cells.
RANK signaling induces the upregulation
of LTa1b2 on the surface of LTi cells (Kon-
ing and Mebius, 2012), allowing them to
efficiently engage the LTbR on LTo cells.
This sequence of events eventually estab-
lishes a feed-forward loop because
signaling through the LTbR leads to
further upregulation of chemokines,
adhesion molecules, and, additionally,
the survival factor interleukin 7 (Koning
and Mebius, 2012). Thus, the problem ofImmunity 37localized reprogramming of preadipo-
cytes is reduced to what the source of ret-
inoic acid in the lymph-node anlagen
might be. Interestingly, nerve cells situ-
ated in the lymph-node anlagen express
high amounts of retinaldehyde dehydro-
genase 2 (RALDH2), a rate-limiting
enzyme in the stepwise conversion of
vitamin A to retinoic acid (van de Pavert
et al., 2009). This observation suggested
that the paracrine provision of retinoic
acid from nerve cells to LTo precursors
(that is, preadipocytes) initiates the
cascade of cellular differentiation and
interaction events eventually resulting in
a functional lymph node. Because nerve
endings are positioned in only very
specific regions of the fat pad that ulti-
mately encapsulates the developing
lymph node, the developmental require-
ment for spatial restriction of retinoic-
acid signaling is fulfilled (Figure 1). In
conclusion, the results of Be´ne´zech et al.
(2012) provide pivotal information ex-
plaining an early and crucial step of
lymph-node formation.
However, the identification of preadipo-
cytes as the origin of lymph-node orga-
nizer cells by Be´ne´zech et al. (2012) has
implications beyond merely a better
understanding of the ontogeny of lymph-
node development. From an evolu-
tionary perspective, their findings provide
another intriguing link between the emer-
gence of LNs and the expansion of the
TNF-receptor gene family, in which the
gene encoding LTbR is the most relevant
in this context. It appears that this facility
of LTbR signaling in preadipocytes repre-
sents an evolutionary innovation that, on
the one hand, enables the suppression
of an ancient default pathway (adipocyte
development) and, on the other, allows
for the reprogramming into an evolution-
arily novel cell lineage, LTo cells. Interest-
ingly, signaling through LTbR was also
installed in thymic medullary epithelial
cells (mTECs), an evolutionarily ancient
part of the adaptive immune system.
Here, LTbR signaling regulates lymphoe-
pithelial cross-talk; in the absence of
LTbR, the fact thatmTECs do not differen-
tiate correctly is associated with retention
of mature T lympohoyctes and autoim-
mune phenomena (Boehm et al., 2003).
These examples indicate that despite its
relatively young age—in terms of evolu-
tionary time scales—the LTbR-encoding
gene has proven a highly versatile, October 19, 2012 ª2012 Elsevier Inc. 597
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Previewsaddition to the genetic networks of
immune functions.
The work by Be´ne´zech et al. (2012)
might also be relevant to our under-
standing of the relationship between
obesity and inflammation, a relationship
which is becoming increasingly recog-
nized as a major contributor to chronic
illness and immune-related metabolic
disorders (Osborn and Olefsky, 2012). If
indeed adult preadipocytes are suscep-
tible to reprogramming to LTo cells by
local tissue inflammation, this might
explain why adipose tissue often contains
aberrant lymphoid tissue. In this context,
it is worth noting that dendritic cells
express high amounts of RALDH2 (Szat-
mari et al., 2006); therefore, in the adult,
these cells might provide the initiating
retinoic-acid stimulus to set in motion
the self-perpetuating process of (in this
case, aberrant) lymphoid-tissue forma-
tion. Secondary lymphoid-tissue forma-
tion is completed soon after birth and
appears to be no longer dependent on598 Immunity 37, October 19, 2012 ª2012 Elinitiating signals such as retinoic acid;
hence, it might be possible to interfere
with ongoing tertiary lymphoid-tissue
formation associated with tissue inflam-
mation in the adult organism without dis-
rupting the function of already established
lymphoid tissues.
Finally, the work by Be´ne´zech et al.
(2012) provides an unexpected and very
welcome boost to efforts aimed at con-
structing artificial lymph-node structures
(Kobayashi et al., 2011). Preadipocytes,
the newly identified precursors of LTo
cells, are plentiful in adipose tissue;
hence, they provide a readily available
source suitable for the in vitro generation
of LTo cells, for instance, by successive
treatment with retinoic acid and agonistic
LTbR antibodies. In view of the self-
enforcing nature of LTo-LTi interactions
described above, it is reasonable to
expect that transplantation of such artifi-
cially generated LTo cells into suitable
tissue sites will lead to the formation of
genuine LN- like structures.sevier Inc.REFERENCES
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The contraction of T cell populations after immune responses is poorly understood. In this issue of Immunity,
Singh et al. show that ‘‘deletor’’ T cells regulate the frequency of antigen-specific T cells by competing for
shared subthreshold ligands.We have known for some time that the
peripheral T cell pool remains roughly
the same size despite the repeated
perturbations associated with infection.
However, regulation of cell number is
only half the story: for the T cell pool to
function effectively, it is the quality, not
just the quantity, of its membership that
counts. Faced with an unpredictable anti-
genic future, breadth of repertoire is key.
In this regard, how the immune repertoire
is preserved despite regular episodes
of clonal expansion has puzzled immuno-logists. If restoration of T cell numbers
after such events were simply regulated
by competition for generic resources,
one might expect the concurrent loss of
‘‘bystander’’ T cells and a gradual narrow-
ing of the repertoire over time.
In this issue of Immunity, Singh et al.
(2012) report a regulatory mechanism
that they propose minimizes the risk of
repertoire contraction after immune
responses. Their initial quest was to
unravel why T cells respond so differently
in lymphopenic hosts compared withintact ones. It is widely appreciated that
lymphopenia provokes bad behavior in
T cells—consequently, numerous models
of autoimmunity exploit lymphopenia
to promote pathology. Indeed, in the
authors’ own model, in which T cell
receptor (TCR) transgenic CD4+ T cells
(5C.C7 cells) were transferred into mice
systemically expressing their cognate
antigen (pigeon cytochrome C [PCC]),
autoimmune arthritis occurred only if
the recipient mice lacked other T cells.
What is surprising is the explanation that
